BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 19675882)

  • 21. [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].
    Spitzweg C
    Internist (Berl); 2003 Apr; 44(4):396-402, 404-8, 410-1. PubMed ID: 12914397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
    Carvalho DP; Ferreira AC
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.
    Dohán O; Carrasco N
    Mol Cell Endocrinol; 2003 Dec; 213(1):59-70. PubMed ID: 15062574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium iodide symporter: its role in nuclear medicine.
    Chung JK
    J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The practical relevance of the sodium iodide symporter].
    Spitzweg C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.
    Bizhanova A; Kopp P
    Endocrinology; 2009 Mar; 150(3):1084-90. PubMed ID: 19196800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium iodide symporter-based strategies for diagnosis and treatment of thyroidal and nonthyroidal malignancies.
    Heufelder AE; Morgenthaler N; Schipper ML; Joba W
    Thyroid; 2001 Sep; 11(9):839-47. PubMed ID: 11575853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
    Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
    Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A perspective view of sodium iodide symporter research and its clinical implications.
    Riesco-Eizaguirre G; Santisteban P
    Eur J Endocrinol; 2006 Oct; 155(4):495-512. PubMed ID: 16990649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sodium/iodide symporter: state of the art of its molecular characterization.
    Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium iodide symporter in health and disease.
    Shen DH; Kloos RT; Mazzaferri EL; Jhian SM
    Thyroid; 2001 May; 11(5):415-25. PubMed ID: 11396700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
    Schmutzler C; Köhrle J
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biology and clinical application of the NIS gene.
    Elisei R; Vivaldi A; Pacini F
    Tumori; 2003; 89(5):523-8. PubMed ID: 14870777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [
    Jiang H; DeGrado TR
    Theranostics; 2018; 8(14):3918-3931. PubMed ID: 30083270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium/iodide symporter in thyroid cancer.
    Mian C; Lacroix L; Bidart JM; Caillou B; Filetti S; Schlumberger M
    Exp Clin Endocrinol Diabetes; 2001; 109(1):47-51. PubMed ID: 11573140
    [No Abstract]   [Full Text] [Related]  

  • 37. The Na+/I- symporter (NIS): mechanism and medical impact.
    Portulano C; Paroder-Belenitsky M; Carrasco N
    Endocr Rev; 2014 Feb; 35(1):106-49. PubMed ID: 24311738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sodium iodide symporter in physiology and diseases -- the current state of knowledge].
    Wolny M; Syrenicz A
    Endokrynol Pol; 2007; 58(6):512-21. PubMed ID: 18205108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
    De La Vieja A; Dohan O; Levy O; Carrasco N
    Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer.
    Riedel C; Dohán O; De la Vieja A; Ginter CS; Carrasco N
    Trends Biochem Sci; 2001 Aug; 26(8):490-6. PubMed ID: 11504625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.